कृपया अन्य खोज का प्रयास करें
चिन्ह | एक्सचेंज | करेंसी | ||
---|---|---|---|---|
2269 | हांगकांग | HKD | देरी | |
WXIBF | OTC Markets | USD | देरी |
WuXi Biologics (Cayman) Inc., an investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia. It operates through two segments: Biologics and XDC. The company provides a suite of solutions for biologic discovery, from concept to IND, that seamlessly transits to CMC and downstream process development through its contract research, development, and manufacturing organization platforms, including WuXiBody, SDArBodY, T cell engager, Single B Cell Cloning Technology, WuXia, WuXiUP, WuXiUI, and WuXiHigh. It also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, production and sales of medicals, and biologics clinical and manufacturing services; production and sale of medicals; vaccine contract development and manufacturing organization (CDMO) and related business; and engages in investment and material supplier activities. The company has a research service agreement with BioNTech SE to discover and investigate monoclonal antibodies for developing next-generation therapeutic product candidates. The company was incorporated in 2014 and is headquartered in Wuxi, China.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Ge Li | 56 | 2014 | Founder & Chairman |
Zhisheng Chen | 50 | 2014 | CEO & Executive Director |
Weichang Zhou | 60 | 2015 | Honorary President of Global Biologics Development, Senior Advisor to CEO & Non-Executive Director |
Kenneth Walton Hitchner | 63 | 2020 | Independent Non-Executive Director |
Jue Chen | 54 | 2023 | Independent Non-Executive Director |
Yibing Wu | 56 | 2016 | Non-Executive Director |
Yanling Cao | 40 | 2016 | Non-Executive Director |
William Robert Keller | 76 | 2017 | Independent Non-Executive Director |
James W. Larrick | - | 2018 | Member of Scientific Advisory Board |
Wei-Shou Hu | - | 2018 | Member of Scientific Advisory Board |
Jackson Peter Tai | 74 | 2023 | Independent Non-Executive Director |
Ram Sasisekharan | 59 | 2018 | Member of Scientific Advisory Board |
David D. Ho | 71 | 2018 | Member of Scientific Advisory Board |
Rolf G. Werner | - | 2023 | Member of Scientific Advisory Board |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है